| 1 | 1351636-18-4 | 替拉鲁替尼 | Btk Kinase inhibitor | C25H22N6O3
| 中间体 - 医药中间体 | |
| 2 | 1216502-48-5 | CANDESARTAN-D5 METHYL ESTER | Candesartan-d5 Methyl Ester | C25H22N6O3
| | |
| 3 | 139481-69-9 | 2-乙氧基-1-[[(2'-(1H-四唑-5-基)联苯-4-基)甲基]苯并咪唑]-7-甲酸甲酯 | Methyl-2-Ethoxy-1-[[(2'-(1h-Tetrazol-5-Yl)Biphenyl-4-Yl)Methyl]Benzimidazole]-7-Carboxylate | C25H22N6O3
| 中间体;对照品;医药原料;坎地沙坦酯中间体;药物杂质及中间体 | |
| 4 | 1351636-25-3 | 8h-purin-8-one, 6-amino-7,9-dihydro-9-[1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)- | 8h-purin-8-one, 6-amino-7,9-dihydro-9-[1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)- | C25H22N6O3
| | |
| 5 | 212322-77-5 | N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine | N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine | C25H22N6O3
| | |